Zusammenfassung
Primäre intrakranielle Tumoren gehen vom Gehirn, den Hirnhäuten (Meningen) und seinen Anhangsgebilden (Hypophyse, Epiphyse) aus. Sie lösen durch Kompression, Infiltration, Ischämie oder Irritation neurologische Symptome aus. Sekundäre Hirntumoren sind Metastasen eines extrazerebralen Primärtumors, dessen Tochterzellen in der Regel hämatogen ins Gehirn gelangen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Zitierte Literatur
Abrey LE, Batchelor TT, Ferreri AJM et al. (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23: 5034–5043
Andrews DW, Scott CB, Sperduto PW et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665–1672
Aoyama H, Shirato H, Tago M et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgrey alone for treatment of brain metastases: A randomised controlled trial. J Am Med Assoc 295: 2483–2491
Bent MJ van den, Afra D, Witte O de et al. (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366: 985–990.
Bent MJ van den, Carpentier AF, Brandes AA et al. (2006) Adjuvant Procarbazine, Lomustine, and Vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized European Organisation for Research and Treatment of Cancer Phase III Trial. J Clin Oncol 24 2715–2722
Boedeker CC, Ridder GJ, Schipper J (2005) Paragangliomas of the head and neck: Diagnosis and treatment. Fam Cancer 4(1): 55–59.
Bokstein F, Lossos A, Siegal T (1998) Leptomeningeal metastases from solid tumors: A comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82: 1756–1763
Bruce JN, Ogden AT (2004) Surgical strategies for treating patients with pineal region tumors. J Neurooncol 69: 221–236
Caceres A (2005) Intracavitary therapeutic options in the management of cystic craniopharyngioma. Childs Nerv Syst 21: 705–718
Cairncross G, Berkey B, Shaw E et al. (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24: 2707–2714
Combs SE, Thilmann C, Edler L et al. (2005) Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol 23: 8863–8869
Cuccia V, Rodriguez F, Palma F et al. (2006) Pinealoblastomas in children. Childs Nerv Syst 22: 577–585
DeAngelis LM (2001) Brain tumors. N Engl J Med 344: 114–123
DeAngelis LM, Gutin PH, Leibel SA et al. (2002) Neoplastic cysts and cyst-like tumors. In: DeAngelis LM, Gutin PH, Leibel SA et al. (eds) Intracranial tumors. London: Martin Dunitz, pp 356–366
Debus J, Wuendrich M, Pirzkall A et al. (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: Longterm results. J Clin Oncol 19: 3547–3553
De Munnynck K, Van Gool S, Van Calenbergh F et al. (2002) Desmoplastic infantile ganglioglioma: A potentially malignant tumor? Am J Surg Pathol 26: 1515–1522
Ekenel M, Iwamoto FM, Ben-Porat LS et al. (2008) Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer 113(5): 1025–1031
Friedman H, Prados MD, Wen PY et al. (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27 (28): 4733–4740
Fischer L, Martus P, Weller M et al. (2008) Meningeal dissemination in primary CNS lymphoma: Prospective evaluation of 282 patients. Neurology 71: 1102–1108
Fuentes R, Bonfill X, Exposito J (2006) Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. Cochrane Database Syst Rev 1, CD004840
Glantz MJ, Cole BF, Recht L et al. (1998) High-dose intravenous methotrexate for patients with nonleukemic cancer: Is intrathecal chemotherapy necessary? J Clin Oncol 16: 1561–1567
Gnekow AK, Kortmann RD, Pietsch T et al. (2004) Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristine chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy – report from the multicenter treatment study for children and adolescents with a low grade glioma – HIT-LGG 1996 – of the Society of Pediatric Oncology and Hematology (GPOH). Klin Pädiatr 216: 331–342
Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: Critical review of clinical trials. Lancet Oncol 7: 241–248
Hartmann C, Meyer J et al. (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1,010 diffuse gliomas. Acta Neuropathol 118 : 469–474
Hegi ME, Diserens AC et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10): 997–1003
Herrlinger U, Förschler H, Küker W et al. (2004). Leptomeningeal metastasis: Survival and prognostic factors in 155 patients. J Neurol Sci 223: 167–178
Hilden JM, Meerbaum S, Burger P (2004) Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry. J Clin Oncol 22: 2877–2884
Illerhaus G, Marks R, Ihorst G et al. (2006) High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. J Clin Oncol 24: 3865–3870
Jahnke K, Thiel E, Martus P et al. (2006) Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Ann Hematol 85: 45–50
Jenkins RB, Blair H, Ballman KV et al. (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66: 9852–9861
Kaloshi G, Benouaich-Amiel A et al. (2007) Temozolomide for low-grade gliomas: Predictive impact of 1 p/19q loss on response and outcome. Neurology 68(21): 1831–1836
Kleihues P, Cavanee (2000) World Health Organization classification of tumours. Pathology and genetics.Tumours of the nervous system. IARC Press, Lyon
Kreisl TN, Kim L et al. (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27(5): 740–745
Kurian KM, Summers DM, Statham PF et al. (2005) Third ventricular chordoid glioma: Clinicopathological study of two cases with evidence for a poor clinical outcome despite low grade histological features. Neuropathol Appl Neurobiol 31: 354–361
Leenstra JL, Rodriguez FJ, Frechette CM et al. (2007) Central neurocytoma: Management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 67(4): 1145–1154
Lönnroth K, Terho M, Kähärä V et al. (2007) Desmoplastic infantile ganglioglioma: Novel aspects in clinical presentation and genetics. Surg Neurol 68(3): 304–308
Louis DN, Ohgaki H, Wiestler OD et al. (2007a) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. The International Agency for Research on Cancer (IARC), 4th edn. IARC Press, Lyon
Luyken C, Blümcke I, Fimmers R et al. (2004) Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101(1): 146–155
Mavrakis AN, Halpern EF, Barker FG 2nd et al. (2005) Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer. Neurology 65: 908–911
McGirt MJ, Chaichana KL et al. (2008) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110(1): 156–162
Packer RJ, Gajjar A, Vezina G et al. (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24: 4202–4208
Patchell RA, Tibbs PA, Walsh JW et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500
Patchell RA, Tibbs PA, Regine WF et al. (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Jama 280: 1485–1489
Reifenberger G, Louis DN (2003) Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62: 111–126
Rosenblum MK, Matsutani M, Van Meir EG (2000) CNS germ cell tumors. In: Kleihues P, Cavanee W (eds) Pathology and genetics of tumors of the Nervous System. IARC Press, Lyon, pp 208–214
Roa W, Brasher PM, Bauman G et al. (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol 22: 1583–1588
Sawamura Y, Tribolet ND de (2006) Tumors of the pineal region. In: Tonn J-C, Westphal M, Rutka JT et al. (eds) Oncology of CNS tumors. Springer, Berlin Heidelberg New York Tokyo, pp 208–215
Schlegel U, Korfel A, Thiel E et al. (2009) Primäre ZNS Lymphome. Onkologe 15: 211–221
Shah GD, Yahalom J, Correa DD et al. (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25: 4730–4735
Silvani A, Eoli M, Salmeggi A et al. (2005) Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: A single-institution study. J Neurooncol 71: 271–276
Smith JS, Chang EF et al. (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26(8): 1338–1345
Stummer W, Pichlmeier U, Meinel T et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 7: 392–401
Stupp R, Mason WP, Van den Bent MJ et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for patients with newly diagnosed glioblastoma. N Engl J Med 352: 987–996
Stupp R, Hegi ME et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 10(5): 459–466
Tekautz TM, Fuller CE, Blaney S et al. (2005) Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23: 1491–1499
Vecht CJ, Breemen M van (2006) Optimizing therapy of seizures in patients with brain tumors. Neurology 67 (Suppl 4): 10–13
Vredenburgh JJ, Desjardins A et al. (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25(30): 4722–4729
Weller M (Hrsg) (2008a) Für die Neuro-Onkologische Arbeitsgemeinschaft (NOA) in der Deutschen Krebsgesellschaft. Leitlinie Diagnostik und Therapie der zerebralen Metastasen. Zuckschwerdt, München
Weller M (Hrsg) (2008b) Für die Neuro-Onkologische Arbeitsgemeinschaft (NOA) in der Deutschen Krebsgesellschaft. Leitlinie Diagnostik und Therapie der Spinalen Metastasen und der Meningeosis neoplastica. Zuckschwerdt, München
Westphal M, Tonn JC (2006) Meningiomas and meningeal tumors. In: Tonn JC, Westphal M, Rutka JT et al. (Hrsg) Neuro-Oncology of CNS Tumors. Springer, Berlin Heidelberg New York Tokyo, pp 81–101
Wick W, Steinbach JP, Küker WM et al. (2004) One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma. Neurology 62: 2113–2115
Wick A, Pascher et al. (2009a) Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol 256(5): 734–741
Wick W, Hartmann C, Engels C et al. (2009b) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35): 5874–5880
Wrede B, Liu P, Ater J et al. (2005) Second surgery and the prognosis of choroid plexus carcinoma – results of a meta-analysis of individual cases. Anticancer Res 25: 4429–4433
Yan H, Parsons DW et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8): 765–773
Yen CP, Sheehan J, Patterson G et al. (2006) Gamma knife surgery for metastatic brain stem tumors. J Neurosurg 105: 213–219
Yung WK, Prados MD, Yaga-Tur R et al. (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 17: 2762–2771
Weiterführende Literatur
Diener HC, Putzki N et al. für die DGN (Hrsg) (2008) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart
Louis DN, Ohgaki H, Wiestler OD et al. (2007a) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. The International Agency for Research on Cancer (IARC), 4th edn. IARC Press, Lyon
Schlegel U, Weller M, Westphal M (Hrsg) (2009) Neuroonkologische Therapie. Kohlhammer, Stuttgart
Tonn J-C, Westphal M, Rutka JT et al. (eds) Oncology of CNS tumors. Springer, Berlin Heidelberg New York Tokyo
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schlegel, U. (2011). Hirntumoren. In: Berlit, P. (eds) Klinische Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16920-5_32
Download citation
DOI: https://doi.org/10.1007/978-3-642-16920-5_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16919-9
Online ISBN: 978-3-642-16920-5
eBook Packages: Medicine (German Language)